Cosmo holds 94.7% of BioXell voting rights and shares
BioXell S.p.A. announced that, on 8 February 2010, which is the end of the offer period, Cosmo Pharmaceuticals S.p.A. holds 94.773 percent of the shares, respectively voting rights of BioXell S.p.A, Milano. This announcement is made in connection with the recommended public tender offer of Cosmo Pharmaceuticals S.p.A. for the shares of BioXell. An additional acceptance period begins on 15 February 2010 and ends on 26 February 2010.
Until the end of the offer period on 8 February 2010, 5,100,300 shares of BioXell with a par value of EUR 5 each have been tendered under the public offer of 8 December 2009 made to the shareholders of BioXell. This corresponds to 94.773 percent of all BioXell Shares, respectively of all shares, which the Offer refers to. Aside from the BioXell Shares tendered under the Offer, Cosmo did not acquire any BioXell Shares or any other equity securities. Thus, as of the end of the offer period and subject to the execution of the Offer, Cosmo (including the persons acting in concert with Cosmo) holds a total of 5,100,300 BioXell Shares corresponding to 94.773 percent of the shares respectively voting rights of BioXell.
This result is provisional and is subject to the final evaluation of the declarations of acceptance of the shareholders of BioXell. Cosmo will publish the final interim result on 12 February 2010.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
